The World Health Organisation (WHO) has called for urgent, coordinated action across human health, agriculture, animal health and environmental sectors to tackle antimicrobial resistance (AMR), warning that inadequate funding, weak surveillance and fragmented interventions are undermining efforts to contain the growing threat.
The organisation said bacterial antimicrobial resistance was associated with more than 4.7 million deaths globally in 2021, stressing that tackling the crisis requires a comprehensive approach beyond hospitals and healthcare facilities.
The Director of WHO’s Department of Antimicrobial Resistance, Dr Jean-Pierre Nyemazi, made the call at the sixth Annual Global Media Forum on AMR ahead of the 2026 World AMR Awareness Week, scheduled for November 18 to 24, with the theme, “One Health, One Action: Prevent AMR Now.”
Nyemazi identified the misuse and overuse of antimicrobials, inadequate infection prevention, poor water and sanitation, and environmental contamination as major drivers of drug resistance. He expressed concern that despite global commitments to tackle AMR, implementation remained weak due to limited financing, fragmented coordination and inadequate surveillance.
At the 2024 United Nations General Assembly High-Level Meeting on AMR, world leaders committed to reducing bacterial AMR-associated deaths by 10 per cent by 2030, against the 2019 baseline of 4.95 million. They also pledged to ensure that at least 60 per cent of countries had funded national AMR action plans by 2030 and mobilise at least $100 million in catalytic funding. “However, let’s be honest. The gap between commitments and pledges versus implementation remains wide,” Nyemazi said.
He disclosed that the updated Global Action Plan on AMR for 2026–2036 had been finalised and was expected to be launched at the Fifth Global High-Level Ministerial Conference on AMR scheduled to hold in Abuja from December 6 to 8, 2026. The plan prioritises prevention, cross-sector surveillance, responsible antimicrobial use, stronger laboratories, equitable access to medicines and sustainable financing.
Also speaking, the Senior Technical Officer and Lead of Multisectoral Coordination in WHO’s AMR Department, Dr Kefas Samson, identified inadequate financing, weak surveillance, limited diagnostic capacity, poor infection prevention in healthcare facilities and shortages of health workers as major obstacles.
He said WHO was strengthening monitoring towards the 2030 targets, including ensuring that 70 per cent of antibiotics used in human health belong to the WHO Access group and that 80 per cent of countries can test for priority bacterial and fungal pathogens.
Beyond healthcare facilities, the Food and Agriculture Organisation of the United Nations (FAO) warned that global antibiotic use in livestock could increase by nearly 30 per cent by 2040 without intervention. Its Deputy Chief Veterinarian, Dr Junxia Song, said improved animal health services and better farm management practices could reduce antibiotic use by up to 57 per cent.
READ ALSO:
- NCH: Health Leaders Urged To Translate Resolutions Into Results
- Tinubu Seeks End to Jail Terms for Attempted Suicide
- Group Protests N88.67trn Debt Figures, Seeks DMO Records
She called for greater investment in disease prevention, veterinary services and responsible antimicrobial use, noting that FAO’s 10-year Reduce the Need for Antimicrobials on Farms (RENOFARM) initiative had attracted more than 400 partners, including over 80 member countries.
Similarly, the United Nations Environment Programme (UNEP) warned that environmental pollution could undermine efforts to contain AMR. Its AMR Coordinator, Aitziber Echeverria, said pharmaceutical manufacturing, agriculture and food systems, healthcare facilities, and municipal waste and wastewater management required urgent attention.
She called for stronger environmental surveillance, investment in wastewater treatment, safe disposal of medicines and improved laboratory capacity, stressing that environmental authorities must be integrated into national AMR action plans.
On animal health, the World Organisation for Animal Health (WOAH) called for increased investment in vaccination, farm biosecurity, surveillance and veterinary services to prevent infections and reduce antimicrobial use. Its Programme Officer, Dr Jane Lwoyero, said every dollar invested in preventing animal diseases and strengthening animal health systems could generate a return of $28. She noted that animal diseases caused estimated annual losses of up to $300 billion globally, while fewer than 20 per cent of WOAH member countries vaccinated animals against notifiable diseases.
Lwoyero also raised concerns over antimicrobial use for animal growth promotion, noting that countries permitting the practice used 45 per cent more antimicrobials than those that prohibited it. Although global antimicrobial use in animals declined by three per cent between 2019 and 2024, she called for stronger regulation, responsible use and sustainable financing for veterinary services.
Meanwhile, the Chairperson of the Global AMR Media Alliance (GAMA), Shobha Shukla, called for greater public awareness of the dangers of antimicrobial misuse and overuse. She warned that even routine injuries, such as cuts and needle pricks, could expose people to drug-resistant infections that might become difficult or impossible to treat. She urged countries to strengthen prevention while ensuring that people who genuinely need effective medicines have access to them.
Nyemazi urged journalists to sustain public attention on AMR through accurate, evidence-based and solutions-focused reporting, noting that the media had a critical role in shaping public understanding and holding institutions accountable. He said the December ministerial conference in Abuja would provide an opportunity for countries to review progress, address implementation challenges and renew political commitments, stressing that global pledges would only matter when translated into tangible results in communities.
